openPR Logo
Press release

Beta-Glucan Market Size, Share, Price | Industry Report 2022

03-28-2017 09:44 AM CET | Health & Medicine

Press release from: RNR Market Research

Beta-Glucan

Beta-Glucan

“Beta-Glucan Market Size, Share, Price | Industry Report 2022” Market Research Report to It’s a Database.

Download sample copy of This Report @ https://goo.gl/OLkX2p

The beta-glucan market was valued at USD 307.8 million in 2016, and is expected to grow at a CAGR of 7.57%, to reach USD 476.5 million by 2022. The market is primarily driven by factors such as growing health consciousness among consumers and the increasing health expenditure. North America is projected to be the fastest-growing region as the consumers in are gradually becoming aware of the health benefits of oat beta-glucan and its significance in enhancing the body’s immunity. One of the major restraints in the growth of the beta-glucan market is the inconsistency in regulatory norms governing beta-glucan.

On the basis ofsource, the beta-glucanmarketwas led by the cerealsegment, followed by yeast. Cereal is sourced mainly from oats and barley as they contain the highest amount of beta-glucan.

On the basis of category, the beta-glucan market was led by the soluble segment, followed byinsoluble beta-glucan. Products containing soluble beta-glucan are fortified with food to act against diseases such as coronary heart disease, diabetes, and obesity, which are predominant in developed countries. Insoluble beta-glucan is fibrous, which is vital for a healthy digestive system.

Break-up of Primaries:

• By Company Type: Tier 1 – 45 %, Tier 2 – 30%, and Tier 3 – 25%
• By Designation: Director Level: – 15%, C Level – 50%, and Others – 35%
• By Region: North America – 55%, Europe – 20%, Asia-Pacific –20%, and RoW - 5%

Request for discount of This Report @ https://goo.gl/qoOXpn

Key points from table of content:

Company Profiles :

• Cargill (U.S.)
• Kerry Group plc (Israel)
• Tate & Lyle (U.K.)
• Royal DSM (Netherlands)
• Ohly (Germany)
• Frutarom (Israel)
• MilliporeSigma (U.S.)
• Super Beta Glucan (U.S.)
• Garuda International (U.S.)
• LesaffreHuman Care (France)

About RnRMarketResearch :

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us :

RnR Market Research
Corporate Headquarters
2nd floor, metropole,
Next to inox theatre,
Bund garden road, Pune-411001.
+ 1 888 391 5441
sales@rnrmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beta-Glucan Market Size, Share, Price | Industry Report 2022 here

News-ID: 483979 • Views:

More Releases from RNR Market Research

Emerging Trends Exosome Diagnostics and Therapeutics Market Dominated by Evox Th …
An exosome diagnostic and therapeutic study approach represents the opportunity to expand and develop the liquid biopsy market, a growing sector in cancer diagnostics. Once they reach the recipient cells, cytoplasmic ingredients can alter their biology. Access Sample Papers of Exosome Diagnostics and Therapeutics Market with 248 Pages and 6 Company Profiles Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1529771 . Growth in exosome diagnostic and therapeutic market in these regions attributes to the technological advancement in
17.8% CAGR for Care Management Solutions Market - Regions Like North America and Europe Drives the Growth
17.8% CAGR for Care Management Solutions Market - Regions Like North America and …
Key care management solutions market players are Allscripts Healthcare Solutions, Inc. (U.S.), TriZetto Corporation (U.S.), Phytel Inc. (U.S.), EXL Healthcare (U.S.), AxisPoint Health (U.S.), Wellcentive, Inc. (U.S.), Medecision, Inc. (U.S.), ZeOmega Inc. (U.S.), i2i Systems, Inc. (U.S.), HealthSmart Holdings, Inc. (U.S.), Pegasystems Inc. (U.S.), Epic Corporation Inc. (U.S.), and Harmony Information Systems, Inc. (U.S.) Download Brochure of Care Management Solutions Market spread across 191 pages, Profiling 15 Companies and Supported with
Global 5K Display Resolution Market: 2019 Industry Analysis, Size, Trends, Growth and Forecast 2025 | Canon Inc, Samsung Electronics, Sony Corporation, LG Electronics Inc, Sharp Corporation, Philips, HP, Others
Global 5K Display Resolution Market: 2019 Industry Analysis, Size, Trends, Growt …
This report presents the worldwide 5K Display Resolution Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Global 5K Display Resolution Market Report including definitions, classifications, applications and
Dialyzers Market 2019-2025: Global Consumption Value, Sales and Key Companies Pr …
The global Dialyzers Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. This report presents the worldwide Dialyzers Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market

All 5 Releases


More Releases for Beta

Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034. Exactitude Consultancy., Ltd. released a research report
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR). Market Dynamics and Growth Drivers Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much! Apuem Finkenhofstraße 27 60322 Frankfurt am Main Germany Jacob Kearson support@apuem.com More Information: apuem.com/contact We and our community search for the best web apps
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018. Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427 Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026. Heat exchangers are devices that transfer energy between fluids
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Beta-lactam and Beta-lactamase